BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Standigm

Standigm logo

Founded
2015
Geography
South Korea based
Funding
$15.190 M

Standigm applies cutting-edge AI technologies to drug discovery. AI and biology experts team up to build a real-world AI model for the pharmaceutical industry. We currently focus on predicting new indications for existing drugs, called drug repositioning through the deeply trained AI model with molecular features of drug responses and drug uses. Standigm generated tens of drug candidates for cancers, Parkinson’s disease (PD), autism, fatty liver diseases (NASH) and more. We promise practical benefits on time and cost in pharmaceutical industry by eliminating some of the uncertainty in the drug discovery process.

Technologies

AI Companies (Drug Discovery)  


Posts Mentioning This Company

Biopharma Insights

R&D Platform

Standigm currently focuses on predicting new indications for existing drugs, called drug repositioning through deeply trained AI model with molecular features of drug responses and drug uses. Standigm generated tens of drug candidates for cancers, Parkinson’s disease (PD), autism, fatty liver diseases (NASH) and more.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet